Leukemia Inhibitory Factor Receptor (LIFR) Antibody

Este producto es parte de LIFR - LIF receptor subunit alpha
Product Graph
260€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Leukemia Inhibitory Factor Receptor (LIFR) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx103729
tested applications
WB, IHC, IF/ICC

Description

Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetLeukemia Inhibitory Factor Receptor (LIFR)
HostRabbit
ReactivityHuman
Recommended DilutionWB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
PurificationPurified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1100 µl
Size 2200 µl
Size 31 ml
FormLiquid
Tested ApplicationsWB, IHC, IF/ICC
Buffer0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
AvailabilityShipped within 5-7 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP42702
AliasLeukemia inhibitory factor receptor,SWS,SJS2,STWS,CD118,LIF-R,LIF receptor
BackgroundAntibody anti-LIFR
StatusRUO

Descripción

The leukemia inhibitory factor receptor (LIFR), also known as the LIF receptor subunit alpha, is a component of a cytokine receptor complex responsible for mediating the effects of the leukemia inhibitory factor (LIF). LIF is part of the interleukin-6 (IL-6) family of cytokines and is involved in various cellular processes, such as cell survival, proliferation, and differentiation, particularly in neuronal, hematopoietic, and reproductive cells. LIFR is encoded by the LIFR gene, located on chromosome 5p13, and is widely expressed across various tissues, including the placenta, brain, liver, and bone marrow. LIFR functions as a non-signaling receptor subunit and, upon binding to LIF, associates with the co-receptor gp130. Together, this receptor complex initiates intracellular signaling pathways that are central to immune responses, tissue repair, and neural development. LIFR is significant in embryonic development and stem cell maintenance, and dysregulation of LIFR signaling is associated with several diseases, such as inflammatory disorders, cancer, and neurodegenerative diseases.

Related Products

EH0218

Human LIFR(Leukemia inhibitory factor receptor) ELISA Kit

Ver Producto
EM1189

Mouse LIFR(Leukemia Inhibitory Factor Receptor) ELISA Kit

Ver Producto
ER1125

Rat LIFR(Leukemia Inhibitory Factor Receptor) ELISA Kit

Ver Producto